Hong Kong, n/a,
Hong Kong
Sciclone Pharmaceuticals International Technographics
Sciclone Pharmaceuticals International Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Sciclone Pharmaceuticals International and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 10 Sciclone Pharmaceuticals International employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Sciclone Pharmaceuticals International has purchased the following applications: Oracle Cloud EPM for EPM in 2019, Microsoft Entra ID (formerly Azure Active Directory) for Identity and Access Management (IAM) in 2022 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Sciclone Pharmaceuticals International is running and its propensity to invest more and deepen its relationship with Oracle , Microsoft , Mimecast or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Sciclone Pharmaceuticals International revenues, which have grown to $1.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Sciclone Pharmaceuticals International intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Sciclone Pharmaceuticals International Tech Stack and Enterprise Applications
Sciclone Pharmaceuticals International EPM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Oracle | Legacy | Oracle Cloud EPM | EPM | EPM | HAND Enterprise Solutions | 2019 | 2019 |
In 2019, Sciclone Pharmaceuticals International implemented Oracle Cloud EPM Planning to streamline budgeting and forecasting across its China focused operations and improve FP&A accuracy. The deployment established a centralized Oracle Cloud EPM Planning instance under the EPM category to serve planning and financial close workflows for the company’s distribution operations in Hong Kong, China and broader APAC coverage.
Configuration emphasized budgeting and forecasting capabilities within Oracle Cloud EPM Planning, including planning models, scenario planning, and driver based budgeting to replace manual spreadsheet processes and standardize assumptions. Shanghai Hand Enterprise Solutions led implementation tasks such as model design, calculation rule configuration, security roles and data access controls to align planning modules with finance workflows.
Governance changes included centralizing planning ownership in finance, enforcing version control and auditability, and standardizing planning cycles across China and APAC sites. According to the project source, the Oracle Cloud EPM Planning deployment produced measurable cost savings, reduced manual errors in budgeting, and accelerated planning cycles.
|
Sciclone Pharmaceuticals International CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft Entra ID (formerly Azure Active Directory) | Identity and Access Management (IAM) | CyberSecurity | n/a | 2022 | 2022 |
In 2022, Sciclone Pharmaceuticals International implemented Microsoft Entra ID (formerly Azure Active Directory) to centralize identity for web authentication and corporate sign-in. The deployment is visible on their public website and uses Identity and Access Management (IAM) capabilities to secure authentication flows and maintain a single cloud directory for user accounts. The scope is aligned to the companys Hong Kong operations and sized for a small 10-employee distribution firm, favoring a cloud-native tenant model rather than on-premises infrastructure.
Configuration emphasized core Identity and Access Management (IAM) functions typical for the category, including user authentication, single sign-on for web sessions, and user lifecycle provisioning and synchronization. Microsoft Entra ID (formerly Azure Active Directory) was configured to issue identity tokens for website sign-in and to consolidate employee accounts in a central directory. Role and group-based access controls were applied to segment administrative privileges from standard user access within the tenant.
Operationally the implementation anchors the public website authentication to the organizations Microsoft Entra ID tenant, consolidating access policy administration in the cloud directory. Governance is exercised through Entra ID directory controls to centralize account provisioning, group membership, and access policy enforcement for both web-facing and internal sign-in flows. The integration footprint observed is site-centric, with identity services provided by Microsoft Entra ID (formerly Azure Active Directory) as the authoritative identity provider.
|
|
|
|
|
Secure Email Gateways (SEGs) | CyberSecurity |
|
2017 | 2017 |
|
IT Decision Makers and Key Stakeholders at Sciclone Pharmaceuticals International
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Sciclone Pharmaceuticals International Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||